The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
2011

Finding New Drugs for Alzheimer's Disease

Sample size: 88 publication Evidence: moderate

Author Information

Author(s): Lu Shin-Hua, Wu Josephine W, Liu Hsuan-Liang, Zhao Jian-Hua, Liu Kung-Tien, Chuang Chih-Kuang, Lin Hsin-Yi, Tsai Wei-Bor, Ho Yih

Primary Institution: National Taipei University of Technology

Hypothesis

Can we identify new acetylcholinesterase inhibitors using pharmacophore modeling and virtual screening?

Conclusion

The study successfully identified potential acetylcholinesterase inhibitors that may help in treating Alzheimer's disease.

Supporting Evidence

  • The pharmacophore model generated a high correlation coefficient of R = 0.851.
  • The study identified 9 compounds with high pharmacophore fit values.
  • The virtual screening approach successfully retrieved 70% of active compounds.

Takeaway

The researchers created a model to find new drugs that can help people with Alzheimer's by blocking a harmful enzyme in the brain.

Methodology

The study used pharmacophore modeling, virtual screening, and molecular docking to identify potential inhibitors.

Limitations

The study primarily focused on in silico methods and may require further in vitro and in vivo validation.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1423-0127-18-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication